23 November 2017
News and Views
Links and Services
The latest issue of the Alimentary Pharmacology & Therapeutics examines survival advantage after switching to sirolimus in hepatitis C virus infected liver graft recipients.
The use of sirolimus-based immune suppression in liver transplantation, particularly in hepatitis
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors